calendar
4,474 catalysts · 3,153 8k filing · 577 earnings · 249 grant · 179 approval · 172 phase 2 completion · 133 drug shortage
4,474 catalysts · 3,153 8k filing · 577 earnings · 249 grant · 179 approval · 172 phase 2 completion · 133 drug shortage
AI grant. $229,714. PI: Mark T Heise
NS grant. $441,375. PI: Steve C Danzer
DK grant. $826,321. PI: Accalia Fu
AT grant. $787,346. PI: Eric C Martens
AI grant. $580,306. PI: DIONICIA Baziliza GAMBOA VILELA
CA grant. $595,012. PI: Charles Matthew Kinsey
AI grant. $207,995. PI: Simin Zhang
Good Brain Tonic 16 oz & 32 oz
Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL
Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL
Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL
Sponsor: AZURITY. Form: TABLET. Route: ORAL
Sponsor: SAPTALIS PHARMS. Form: CONCENTRATE. Route: ORAL
Sponsor: GERON. Form: POWDER. Route: INTRAVENOUS
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL
Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: CUMBERLAND PHARMS. Form: FOR SOLUTION. Route: ORAL
Sponsor: HALEON US HOLDINGS. Form: CREAM. Route: TOPICAL
Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL
Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL
ES grant. $15,000. PI: Ryan P Barnes
EB grant. $143,201. PI: Robert Herbert
AI grant. $1,106,984. PI: Soumya Rahima Benhabbour
ES grant. $765,348. PI: Randy Carney
AI grant. $403,756. PI: Joseph Thomas Wade
EB grant. $381,392. PI: Jicheng Fu
EB grant. $616,375. PI: Eugene Thomas Pashuck
ES grant. $1,460,280. PI: Chuanxi Cai
AI grant. $196,020. PI: Alyssa K Mezochow
CA grant. $40,000. PI: Michael E. Scheurer
Sponsor: TEVA PHARMS INC. Form: LIQUID. Route: ORAL
Sponsor: BIOCODEX SA. Form: CAPSULE. Route: ORAL
Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION
Sponsor: ALEMBIC. Form: INJECTABLE. Route: INJECTION
Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION
Sponsor: ASTRAZENECA AB. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: AUROBINDO PHARMA. Form: LIQUID
Sponsor: MICRO LABS. Form: TABLET. Route: ORAL
Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL
Sponsor: ASPIRO. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: MSN. Form: LIQUID. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL
Sponsor: BIOCODEX SA. Form: FOR SUSPENSION. Route: ORAL
Sponsor: MYLAN LABS LTD. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION
Sponsor: EDENBRIDGE PHARMS. Form: SOLUTION/DROPS. Route: OPHTHALMIC